Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  New England Journal of Medicine

• Publication date

  1971-12-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM197112092852401PMID 4107718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rubella vaccination. A review of practical experience.

  1971cited by this paper
• A study of rubella immunity and resistance to infection.

  1971cited by this paper
• Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus.

  1971cited by this paper
• Arthritis associated with induced rubella infection.

  1971cited by this paper
• Arthritis Associated with Induced Rubella Infection

  1971cited by this paper
• Rubella Vaccination: A Review of Practical Experience

  1971cited by this paper
• Distribution of Echovirus Antibody in Serum, Nasopharynx, Rectum, and Spinal Fluid After Natural Infection with Echovirus Type 6

  1970cited by this paper
• Concentration of Rubella Virus Antigen in Chondrocytes of Congenitally Infected Rabbits

  1970cited by this paper
• Immunisation of schoolchildren with rubella (RA27-3) vaccine. Intranasal and subcutaneous administration.

  1970cited by this paper
• Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.

  1970cited by this paper
• Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

  1970cited by this paper
• Distribution of Echovirus Antibody in Serum, Nasopharynx, Rectum, and Spinal Fluid After Natural Infection with Echovirus Type 6

  1970cited by this paper
• [Anti-rubella vaccination with Plotkin strain].

  1970cited by this paper
• A controlled family study of live, attenuated rubella-virus vaccine.

  1970cited by this paper
• Attenuated rubella viruses. Laboratory and clinical characteristics.

  1969cited by this paper
• Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees.

  1969cited by this paper
• The control of rubella.

  1969cited by this paper
• Serum IgM and IgG responses in postnatally acquired rubella.

  1969cited by this paper
• Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.

  1969cited by this paper
• Protective efficacy of duck embryo rubella vaccines.

  1969cited by this paper
• Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.

  1969cited by this paper
• Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.

  1969cited by this paper
• Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines.

  1969cited by this paper
• Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella.

  1969cited by this paper
• Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.

  1969cited by this paper
• Epidemiology of rubella. Subclinical infection and occurrence of reinfection.

  1969cited by this paper
• Comparative studies of rubella vaccines.

  1969cited by this paper
• Serology of rubella. Virus neutralization, immunofluorescence in BHK21 cells, and hemagglutination inhibition.

  1968cited by this paper
• Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.

  1968cited by this paper
• Oral administration of attenuated rubella virus vaccine (HPV-77). A negative report.

  1968cited by this paper
• Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.

  1968cited by this paper
• Attenuated rubella virus. I. Development and laboratory characterization.

  1966cited by this paper
• Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial.

  1966cited by this paper
• THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY

  1964cited by this paper
• THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

  1964cited by this paper
• Recovery of Rubella Virus from Army Recruits

  1962cited by this paper

• Randomized controlled trial on the efficacy of forest walking compared to urban walking in enhancing mucosal immunity

  2025cites this paper
• Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial

  2024cites this paper
• Directed attenuation to enhance vaccine immunity

  2021cites this paper
• Using directed attenuation to enhance vaccine immunity

  2020cites this paper
• Mechanisms of lymphatic system‐specific viral replication and its potential role in autoimmune disease

  2019cites this paper
• Strategic Design of a Vaccine for Tumor-Associated Herpesviruses

  2018cites this paper
• 53 – Rubella Vaccines

  2018cites this paper
• Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection

  2018cites this paper
• Salivary Stress Biomarkers-Are They Predictors of Academic AssessmentExams Stress?

  2016cites this paper
• Parenteral Immunization and Protection from Mucosal Infection

  2015cites this paper
• Rubella Virus (German Measles)

  2015cites this paper
• Vaccines and viral / toxin-associated neurologic infections.

  2014cites this paper
• Australian Population Cohort Study of Newly Arrived Refugee Children: How Effective Is Predeparture Measles and Rubella Vaccination?

  2013cites this paper
• Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus

  2011cites this paper
• Correlates of Protection Induced by Vaccination

  2010cites this paper
• The Virus Laboratory in the Diagnosis and Prevention of Congenital Infections

  2008cites this paper
• Molecular Biology of Rubella Virus

  2008cites this paper
• Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node1

  2008cites this paper
• Immunité et vaccinations antivirales : exemple de la muqueuse respiratoire

  2007cites this paper
• Mucosal and systemic adjuvant activity of alphavirus replicon particles.

  2006cites this paper
• The history of rubella and rubella vaccination leading to elimination.

  2006cites this paper
• Chapter 28 – Rubella

  2006cites this paper
• Measles and rubella vaccination of two million Iranians: Complications in vaccinees aged 5–25 years

  2005cites this paper
• Parenteral Immunization Induces Mucosal Protection: A Challenge to the Mucosal Immunity Paradigm

  2005cites this paper
• Vaccination antivirale et immunité muqueuse respiratoire

  2005cites this paper
• The use of IgM antibody responses in the diagnosis of primary infections to measles, rubella, mumps, andM. Parainfluenzae viruses

  2005cites this paper
• Immunologic correlates of protection induced by vaccination

  2001cites this paper
• IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms.

  2001cites this paper
• Prolonged reduction of salivary immunoglobulin A (sIgA) after a major academic exam.

  2000cites this paper
• Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination.

  1998cites this paper
• Detection of Immunoglobulin G and A Antibodies to Rubella Virus in Urine and Antibody Responses to Vaccine-Induced Infection

  1998cites this paper
• Psychosocial factors and secretory immunoglobulin A.

  1997cites this paper
• A Community Study of Psychological Distress and Immune Function in Women with Family Histories of Breast Cancer.

  1996cites this paper
• [Mumps vaccines: vaccination failures from an immunological viewpoint].

  1995cites this paper
• Mumpsimpfstoffe: Impfversager aus immunologischer Sicht

  1995cites this paper
• Method for determining the equilibrium constant and the concentration of influenza virus IgG antihaemagglutinin antibody molecules by use of EIA titres determined with and without guanidine hydrochloride.

  1994cites this paper
• Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.

  1994cites this paper
• Efficacy of avridine and liposomes as adjuvants for avian influenza virus antigens in turkeys.

  1992cites this paper
• Nasal antibody response to mumps virus after vaccination and natural infection.

  1992cites this paper
• Immunological Principles and Emerging Strategies of Vaccination for the Elderly

  1992cites this paper
• Rubella vaccines: past, present and future

  1991cites this paper
• Vaccination with affinity-purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirus.

  1991cites this paper
• Rubella and mumps vaccines.

  1990cites this paper
• Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (Avidity‐ELISA) and by haemolysis typing

  1989cites this paper
• Stress, Illness, and Secretory Immunity

  1989cites this paper
• Seroepidemiological study of infectious mononucleosis in older patients

  1989cites this paper
• The appearance of viral antigen and antibody in the trachea of naive and vaccinated chickens infected with infectious laryngotracheitis virus.

  1989cites this paper
• Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.

  1989cites this paper
• Molecular analysis of IgA in multiple sclerosis.

  1989cites this paper
• Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge

  1988cites this paper
• Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines.

  1988cites this paper
• Acute rotavirus gastroenteritis in children. Clinical, epidemiological and immunological aspects.

  1988cites this paper
• Viral antibodies in normal tears.

  1988cites this paper
• Induction by cells of immune responses to intestinal epithelial cell-associated components (ECAC): transfer with cultured murine mesenteric and popliteal/axillary lymph node cells.

  1988cites this paper
• Secretory IgA as a measure of immunocompetence.

  1987cites this paper
• Secretory and serum immunoglobulin class-specific antibodies to mumps virus after a natural mumps infection

  1987cites this paper
• Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum

  1987cites this paper
• Separation of hemagglutination-inhibiting immunoglobulin M antibody to rubella virus in human serum by high-performance liquid chromatography

  1986cites this paper
• Viruses and antibody response: An update

  1985cites this paper
• Local immune responses.

  1985cites this paper
• Selective Reactivity ofAntibodies toHumanImmunoglobulins G, M,andA withRubella Virus Proteins

  1985cites this paper
• Potential targets for host defence modulation

  1985cites this paper
• Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.

  1985cites this paper
• Application of an enzyme immunoassay for determinations of humoral IgG and IgM chlamydia antibodies

  1985cites this paper
• Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella

  1985cites this paper
• Selective reactivity of antibodies to human immunoglobulins G, M, and A with rubella virus proteins

  1985cites this paper
• Vaccines: From the research laboratory to their use in the field

  1985cites this paper
• The immune response to herpes simplex virus: Comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections

  1985cites this paper
• Collection of mucosal secretion by synthetic discs for quantitation of secretory IgA and bacteria.

  1984cites this paper
• Caring for the Infectious Patient: Risk Factors During Pregnancy

  1984cites this paper
• Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory

  1983cites this paper
• Rubella vaccination: a course becomes clear.

  1983cites this paper
• Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus

  1983cites this paper
• Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus

  1983cites this paper
• Use of the direct haemolysis-in-gel test for rubella antibodies in the Icelandic prevention programme for congenital rubella.

  1983cites this paper
• Detection of antiviral IgM antibodies and its problems--a review.

  1983cites this paper
• COLOSTRUM‐DERIVED IMMUNITY AND MATERNAL‐NEONATAL INTERACTION

  1983cites this paper
• Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk.

  1982cites this paper
• Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions.

  1982cites this paper
• Immunoglobulin Profiles Provide New Insights into Infectious Diseases

  1982cites this paper
• Immunology of Respiratory Viruses

  1982cites this paper
• Antibody response to varicella-zoster virus after natural or vaccine-induced infection.

  1982cites this paper
• Immunodiagnosis Antibodies in Body Fluids

  1982cites this paper
• Immunology of Measles, Mumps, and Rubella Viruses

  1982cites this paper
• Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines

  1982cites this paper
• The immunoglobulin response to reimmunization with rubella vaccine.

  1981cites this paper
• PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS

  1981cites this paper
• Immunizing agents: potential for controlling or eradicating infectious diseases.

  1981cites this paper
• A Longitudinal Study of Proteins in Maxillary Sinus Secretion from Chronic Sinusitis Patients

  1981cites this paper
• POTENTIAL FOR CONTROLLING OR ERADICATING INFECTIOUS DISEASES

  1981cites this paper
• Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.

  1981cites this paper
• Fetomaternal apects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy.

  1980cites this paper
• Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus

  1980cites this paper
• Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.

  1980cites this paper
• Viral vaccination via the mucosal routes.

  1980cites this paper
• [Virologic diagnosis of rubella. Findings in a rubella epidemic in a military training camp].

  1980cites this paper
• [Virologic diagnostic investigation].

  1980cites this paper
• Comparative evaluation of two lots of Wister RA 27/3 rubella virus vaccine in young children.

  1980cites this paper
• Viral Vaccines and Their Ways

  1979cites this paper
• Maxwell Finland lecture: viral vaccines and their ways.

  1979cites this paper